NasdaqCM - Nasdaq Real Time Price • USD
Ocugen, Inc. (OCGN)
At close: 4:00 PM EDT
After hours: 4:31 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.06 | -0.07 | -0.28 | -0.26 |
| Low Estimate | -0.07 | -0.08 | -0.31 | -0.26 |
| High Estimate | -0.06 | -0.06 | -0.25 | -0.26 |
| Year Ago EPS | -0.07 | -0.1 | -0.26 | -0.28 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | 6.04M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.11 | -0.07 | -0.07 | -0.06 |
| EPS Actual | -0.07 | -0.1 | -0.06 | -0.03 |
| Difference | 0.04 | -0.03 | 0.01 | 0.03 |
| Surprise % | 36.40% | -42.90% | 14.30% | 50.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.07 | -0.28 | -0.26 |
| 7 Days Ago | -0.06 | -0.07 | -0.28 | -0.26 |
| 30 Days Ago | -0.06 | -0.07 | -0.28 | -0.26 |
| 60 Days Ago | -0.06 | -0.07 | -0.28 | -0.26 |
| 90 Days Ago | -0.06 | -0.07 | -0.27 | -0.1 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OCGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 14.30% | -- | -- | 1.60% |
| Next Qtr. | 30.00% | -- | -- | 10.50% |
| Current Year | -7.70% | -- | -- | 5.20% |
| Next Year | 7.10% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/24/2024 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 8/31/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/23/2023 |
| Maintains | Chardan Capital: Buy | 5/8/2023 |
Related Tickers
JAGX Jaguar Health, Inc.
0.1569
-11.41%
PXMD PaxMedica, Inc.
0.7609
-0.29%
LGVN Longeveron Inc.
1.9200
-4.48%
ADIL Adial Pharmaceuticals, Inc.
1.9300
-11.06%
NVAX Novavax, Inc.
3.9700
+2.06%
VXRT Vaxart, Inc.
0.7556
-10.29%
CADL Candel Therapeutics, Inc.
5.17
-5.31%
VERU Veru Inc.
1.3100
-7.75%
RLYB Rallybio Corporation
1.7600
+5.39%
INO Inovio Pharmaceuticals, Inc.
9.68
-5.10%